PREVALENCE OF METABOLIC SYNDROME IN IMPAIRED FASTING GLYCEMIC SUBJECTS.

Abstract

Objectives: The objective of the study was to determine the prevalence of metabolic syndrome in subjects with impaired fasting glucose. Since IFG is an intermediate stage in the development of diabetes and cardiovascular diseases it may be associated with abdominal obesity and atherogenic dyslipidemic profile.

Methods: 50 Subjects with impaired fasting glucose (IFG) and 50 normoglycemic adults in the age group of 18-45 years were selected for the study. Fasting blood samples were collected for glucose and lipid profile. Anthropometric measurements were measured.

Results: The prevalence of metabolic syndrome in patients with IFG according to the National Cholesterol Education Program Adult Treatment Panel (ATP) III was 38% and according to the Consensus definition for adult Asian Indians was 62%.  The prevalence of metabolic syndrome in the euglycemic control group according to the National Cholesterol Education Program Adult Treatment Panel (ATP) III was 24% and according to the Consensus definition for adult Asian Indians was 24%.

Conclusion: The results of this study involving patients with impaired fasting glycemia shows an increased prevalence of metabolic syndrome. Identification of individuals with impaired fasting glycemia  and screening for the presence of metabolic syndrome will help to decrease the morbidity associated with this condition.

Key words: cardiovascular disease, diabetes, impaired fasting glycemia, metabolic syndrome